SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010182
Filing Date
2015-11-09
Accepted
2015-11-09 16:34:39
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aavl-10q_20150930.htm 10-Q 1733867
2 EX-31.1 aavl-ex311_7.htm EX-31.1 14141
3 EX-31.2 aavl-ex312_8.htm EX-31.2 13960
4 EX-32.1 aavl-ex321_9.htm EX-32.1 7315
  Complete submission text file 0001564590-15-010182.txt   6451013

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aavl-20150930.xml EX-101.INS 1414031
6 XBRL TAXONOMY EXTENSION SCHEMA aavl-20150930.xsd EX-101.SCH 44074
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aavl-20150930_cal.xml EX-101.CAL 42069
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aavl-20150930_def.xml EX-101.DEF 183720
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aavl-20150930_lab.xml EX-101.LAB 363526
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aavl-20150930_pre.xml EX-101.PRE 283403
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 151216151
SIC: 2836 Biological Products, (No Diagnostic Substances)